Olver 1GM Inj is primarily indicated in conditions like Abdominal sepsis, Adult febrile neutropenia, Gynecological infections, Meningitis, Obstetric infections, Pneumonia, Pulmonary infections in cystic fibrosis, Septicaemia, Serious infections, Surface anaesthetic, Surgical anaesthesia.
Olver 1GM Inj is contraindicated in conditions like Hypersensitivity, GI diseases.
The severe or irreversible adverse effects of Olver 1GM Inj , which give rise to further complications include Pseudomembranous colitis, Thrombocytopenia, Stevens johnson syndrome, Stevens johnson syndrome, Eosinophilia, Eosinophilia, Seizures. Olver 1GM Inj produces potentially life-threatening effects which include Hypersensitivity reactions. which are responsible for the discontinuation or Olver 1GM Inj therapy. The symptomatic adverse reactions produced by Olver 1GM Inj are more or less tolerable and if they become severe, they can be treated symptomatically, these include Headache, Nausea, Vomiting, Diarrhea, Fever, Constipation, Abdominal pain, Rashes, Urticaria, Pruritus, Elevation of liver enzymes, Dermatitis, Reaction at injection site.
Pseudomembranous colitis and hypersensitivity reactions have occured and often require immediate drug discontinuation, thrombocytopenia has been reported in patients with significant renal dysfunction, seizures have occurred in the patient with underlying neurological disorders (less frequent than with Olver 1GM Inj , safety and efficacy of Olver 1GM Inj have not been established for children